Topic: drug liability

Bayer and J&J agreed to pay $775 million to wrap up about 25,000 lawsuits claiming their Xarelto anticoagulant caused severe bleeding.

Generic drug makers scored a win at the FDA as the agency changed its mind on giving them responsibility to update their labels.

The U.S. is supporting Merck in the Fosamax case, which addresses the question of whether FDA decisions shield pharma from state suits.

A judge struck a large portion of a Roundup verdict against Bayer, but as thousands of lawsuits pile up, the litigation is just getting started.

Right before a trial, Johnson & Johnson inked a settlement to resolve allegations its antipsychotic Risperdal caused a patient to develop breasts.

Merck's ruling at the Supreme Court could affect liability lawsuits across Big Pharma.

A judge has ordered 1,200 Xarelto liability cases against J&J and Bayer to be prepared for trial in courts around the country.

AbbVie has scored a victory in its AndroGel legal saga as more than 4,000 cases await trial.

A judge's new ruling means the first verdict to go against Bayer and Johnson & Johnson over Xarelto's bleeding risks won't stand.

After three wins in cases over the risks of blockbuster blood thinner Xarelto, Bayer and Johnson & Johnson have encountered their first defeat.